标准容量血浆置换改善急性肝衰竭患者结局:一项随机对照试验
这项开放标签随机对照试验将40例急性肝衰竭患者按1:1随机分至标准内科治疗(SMT)组或SMT联合标准容量血浆置换(SVPE)组,主要终点为21天无移植生存。
要点
- SVPE安全,无治疗相关死亡,机制可能与减少细胞因子风暴和氨有关。
核心结论
- 在合并脑水肿的急性肝衰竭患者中,标准容量血浆置换安全有效,可能通过减少细胞因子风暴和氨水平改善生存。
研究设计与样本
- 开放标签随机对照试验,连续纳入40例急性肝衰竭患者,按1:1随机分为标准内科治疗(SMT)组或SMT联合标准容量血浆置换(SVPE)组,采用意向性治疗分析。
主要发现
- 第5天SVPE组较SMT组乳酸清除更高(p=.02),SIRS缓解率84% vs 26%(P=.02)。
- 第5天SVPE组氨水平为(221.5±96.9)vs(439±385.6)μg/dl(P=.02),SOFA评分为9.9(±3.3) vs 14.6(±4.8)(P=.001)。
- SVPE组21天无移植生存率为75% vs 45%(P=.04,HR 0.30,95%CI 0.01-0.88)。
- SVPE组促炎细胞因子水平显著下降、抗炎细胞因子升高,内毒素和DAMPs水平下降。
- 无治疗相关死亡。
关键数值与推荐
- SVPE采用离心式血浆置换,每次目标置换1.5至2.0个血浆容量,直至达到预期反应;平均治疗2.15±1.42次,中位置换血浆容量5.049 L。
- 纳入患者年龄31.5±12.2岁,60%男性,78%病毒性,83%超急性,70%合并SIRS。
临床怎么用
- 对于合并脑水肿的急性肝衰竭患者,可考虑在标准内科治疗基础上联合标准容量血浆置换,以改善21天无移植生存。
- SVPE可能通过降低氨水平、减轻SIRS和细胞因子风暴发挥作用,治疗期间需监测容量状态及脑水肿变化。
局限性
- 原文未报告局限性相关内容。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: High volume plasma-exchange (HVPE) improves survival in patients with acute liver failure (ALF), but apprehension regarding volume overload and worsening of cerebral edema remain. METHODS: In an open-label randomized controlled trial, 40 consecutive patients of ALF were randomized 1:1 to either standard medical treatment (SMT) or SMT with standard-volume plasma-exchange (SVPE). SVPE was performed using centrifugal apheresis [target volume of 1.5 to 2.0 plasma volumes per session] until desired response was achieved. Cerebral edema was assessed by brain imaging. Results were analyzed in an intention-to-treat analysis. Primary outcome was 21-day transplant-free survival. The levels of cytokines, damage-associated molecular patterns (DAMPs) and endotoxins were analyzed at baseline and day 5. RESULTS: ALF patients [aged 31.5 ± 12.2 years, 60% male, 78% viral, 83% hyperacute, 70% with SIRS were included. At day 5, SVPE [mean sessions 2.15 ± 1.42, median plasma volume replaced 5.049 L] compared to SMT alone, resulted in higher lactate clearance (p = .02), amelioration of SIRS (84% vs. 26%; P = .02), reduction in ammonia levels [(221.5 ± 96.9) vs.(439 ± 385.6) μg/dl, P = .02) and SOFA scores [9.9(±3.3) vs. 14.6(±4.8); P = .001]. There were no treatment related deaths. SVPE was associated with a higher 21-day transplant free-survival [75% vs. 45%; P = .04, HR 0.30, 95%CI 0.01-0.88]. A significant decrease in levels of pro-inflammatory cytokines and an increase in anti-inflammatory cytokines along with a decrease in endotoxin and DAMPs was seen with SVPE. CONCLUSION: In ALF patients with cerebral edema, SVPE is safe and effective and improves survival possibly by a reduction in cytokine storm and ammonia. CLINICALTRIAL: gov (identifier: NCT02718079).
引用
- Maiwall R, Bajpai M, Singh A, et al. Standard-Volume Plasma Exchange Improves Outcomes in Patients With Acute Liver Failure: A Randomized Controlled Trial. Clin Gastroenterol Hepatol. 2021. PMID: 33524593. doi:10.1016/j.cgh.2021.01.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。